Skip to main content
Top
Published in: Osteoporosis International 1/2008

01-01-2008 | Original Article

Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions

Authors: M. H. Kelly, B. Brillante, M. T. Collins

Published in: Osteoporosis International | Issue 1/2008

Login to get access

Abstract

Summary

To determine the prevalence, distribution, age-related changes and treatment of pain in fibrous dysplasia, we studied 78 children and adults. Pain was common, more prevalent and intense in adults, sometimes requiring narcotic analgesia. It was often untreated, especially in children, and surprisingly severity did not correlate with skeletal disease burden.

Introduction

Pain is common in fibrous dysplasia (FD), but relatively unstudied. We studied a well-characterized population of patients with a spectrum of disease.

Methods

Thirty-five children (16 male, 19 female, mean age 11.4 (range 5–18)) and 43 adults (15 male, 28 female, 23–62 yrs, mean age 40.3 (range 23–62)) were studied. Bone scans were used to identify the location and extent of disease. The Brief Pain Inventory was used to determine severity.

Results

Pain at sites of FD was common, reported by 67% of the population, but more prevalent and severe in the adult group than the children (81% and 49%, respectively p < 0.005, severity 4.1/10, and 2.8/10, respectively, p < 0.01). Surprisingly, there was no correlation between pain severity and skeletal disease burden. Children were more likely than adults to be untreated for pain (44% vs. 26%).

Conclusions

Pain, which was sometimes severe, was common in subjects with FD. It was often un- or under-treated, especially in children. The prevalence and severity of pain was greater in the adult group, but unrelated to the burden of FD.
Literature
1.
go back to reference Collins MT, Bianco P (2003) Fibrous dysplasia. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. American Society for Bone and Mineral Research, Washington, DC, pp 466–470 Collins MT, Bianco P (2003) Fibrous dysplasia. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. American Society for Bone and Mineral Research, Washington, DC, pp 466–470
2.
go back to reference Bianco P, Robey PG, Wientroub S (2003) Fibrous dysplasia. In: Glorieux FH, Pettifor J, Juppner H (eds) Pediatric bone: biology and disease. Academic Press, Elsevier, New York, NY, pp 509–539 Bianco P, Robey PG, Wientroub S (2003) Fibrous dysplasia. In: Glorieux FH, Pettifor J, Juppner H (eds) Pediatric bone: biology and disease. Academic Press, Elsevier, New York, NY, pp 509–539
3.
go back to reference Bianco P, Riminucci M, Majolagbe A, Kuznetsov SA, Collins MT, Mankani MH, Corsi A, Bone HG, Wientroub S, Spiegel AM, Fisher LW, Robey PG (2000) Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 15:120–128PubMedCrossRef Bianco P, Riminucci M, Majolagbe A, Kuznetsov SA, Collins MT, Mankani MH, Corsi A, Bone HG, Wientroub S, Spiegel AM, Fisher LW, Robey PG (2000) Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 15:120–128PubMedCrossRef
4.
go back to reference Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:1688–1695PubMedCrossRef Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:1688–1695PubMedCrossRef
5.
go back to reference Shenker A, Chanson P, Weinstein LS, Chi P, Spiegel AM, Lomri A, Marie PJ (1995) Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene. Hum Mol Genet 4:1675–1676PubMedCrossRef Shenker A, Chanson P, Weinstein LS, Chi P, Spiegel AM, Lomri A, Marie PJ (1995) Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene. Hum Mol Genet 4:1675–1676PubMedCrossRef
6.
go back to reference Schwindinger WF, Francomano CA, Levine MA (1992) Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89:5152–5156PubMedCrossRef Schwindinger WF, Francomano CA, Levine MA (1992) Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89:5152–5156PubMedCrossRef
7.
go back to reference Lichtenstein L (1938) Polyostotic fibrous dysplasia. Arch Surg 36:874–898 Lichtenstein L (1938) Polyostotic fibrous dysplasia. Arch Surg 36:874–898
8.
go back to reference Lichtenstein L, Jaffe HL (1942) Fibrous dysplasia of bone: a condition affecting one, several or many bones, graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism or still other extraskeletal abnormalities. Arch Path 777–816 Lichtenstein L, Jaffe HL (1942) Fibrous dysplasia of bone: a condition affecting one, several or many bones, graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism or still other extraskeletal abnormalities. Arch Path 777–816
9.
go back to reference Feuillan PP (1997) McCune-Albright syndrome. Curr Ther Endocrinol Metab 6:235–239PubMed Feuillan PP (1997) McCune-Albright syndrome. Curr Ther Endocrinol Metab 6:235–239PubMed
10.
go back to reference Mastorakos G, Mitsiades NS, Doufas AG, Koutras DA (1997) Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. Thyroid 7:433–439PubMedCrossRef Mastorakos G, Mitsiades NS, Doufas AG, Koutras DA (1997) Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. Thyroid 7:433–439PubMedCrossRef
11.
go back to reference Akintoye SO, Chebli C, Booher S, Feuillan P, Kushner H, Leroith D, Cherman N, Bianco P, Wientroub S, Robey PG, Collins MT (2002) Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab 87:5104–5112PubMedCrossRef Akintoye SO, Chebli C, Booher S, Feuillan P, Kushner H, Leroith D, Cherman N, Bianco P, Wientroub S, Robey PG, Collins MT (2002) Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab 87:5104–5112PubMedCrossRef
12.
go back to reference Collins MT, Chebli C, Jones J, Kushner H, Consugar M, Rinaldo P, Wientroub S, Bianco P, Robey PG (2001) Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 16:806–813PubMedCrossRef Collins MT, Chebli C, Jones J, Kushner H, Consugar M, Rinaldo P, Wientroub S, Bianco P, Robey PG (2001) Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 16:806–813PubMedCrossRef
13.
go back to reference McCune DJ (1936) Osteitis fibrosa cystica: the case of a nine-year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 743–744 McCune DJ (1936) Osteitis fibrosa cystica: the case of a nine-year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 743–744
14.
go back to reference Albright F, Butler AM, Hampton AO, Smith P (1937) Syndrome characterized by osteitis fibrosa disseminata, areas, of pigmentation, and endocrine dysfunction, with precocious puberty in females: report of 5 cases. N Engl J Med 216:727–746CrossRef Albright F, Butler AM, Hampton AO, Smith P (1937) Syndrome characterized by osteitis fibrosa disseminata, areas, of pigmentation, and endocrine dysfunction, with precocious puberty in females: report of 5 cases. N Engl J Med 216:727–746CrossRef
15.
go back to reference Leet AI, Chebli C, Kushner H, Chen CC, Kelly MH, Brillante BA, Robey PG, Bianco P, Wientroub S, Collins MT (2004) Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome. J Bone Miner Res 19:571–577PubMedCrossRef Leet AI, Chebli C, Kushner H, Chen CC, Kelly MH, Brillante BA, Robey PG, Bianco P, Wientroub S, Collins MT (2004) Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome. J Bone Miner Res 19:571–577PubMedCrossRef
16.
go back to reference Chapurlat R, Meunier PJ (1998) Bisphosphonates and bone remodeling: effectiveness in Paget’s disease, fibrous dysplasia and osteoporosis. Rev Chir Orthop Reparatrice Appar Mot 84:743–751PubMed Chapurlat R, Meunier PJ (1998) Bisphosphonates and bone remodeling: effectiveness in Paget’s disease, fibrous dysplasia and osteoporosis. Rev Chir Orthop Reparatrice Appar Mot 84:743–751PubMed
17.
go back to reference Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH (2003) Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab 88:4569–4575PubMedCrossRef Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH (2003) Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab 88:4569–4575PubMedCrossRef
18.
go back to reference DiCaprio MR, Enneking WF (2005) Fibrous dysplasia. Pathrophysiology, evaluation, and treatment. J Bone Joint Surg Am 87:1848–1864PubMedCrossRef DiCaprio MR, Enneking WF (2005) Fibrous dysplasia. Pathrophysiology, evaluation, and treatment. J Bone Joint Surg Am 87:1848–1864PubMedCrossRef
19.
go back to reference Ippolito E, Bray EW, Corsi A, De Maio F, Exner UG, Robey PG, Grill F, Lala R, Massobrio M, Pinggera O, Riminucci M, Snela S, Zambakidis C, Bianco P (2003) Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J Pediatr Orthop B 12:155–177PubMedCrossRef Ippolito E, Bray EW, Corsi A, De Maio F, Exner UG, Robey PG, Grill F, Lala R, Massobrio M, Pinggera O, Riminucci M, Snela S, Zambakidis C, Bianco P (2003) Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J Pediatr Orthop B 12:155–177PubMedCrossRef
20.
go back to reference Kelly MH, Brillante B, Kushner H, Gehron Robey P, Collins MT (2005) Physical function is impaired but quality of life preserved in patients with fibrous dysplasia of bone. Bone 37:388–394PubMedCrossRef Kelly MH, Brillante B, Kushner H, Gehron Robey P, Collins MT (2005) Physical function is impaired but quality of life preserved in patients with fibrous dysplasia of bone. Bone 37:388–394PubMedCrossRef
21.
go back to reference McCaffery M, Pasero C (1999) Pain clinical manual. Mosby, Inc, St Louis McCaffery M, Pasero C (1999) Pain clinical manual. Mosby, Inc, St Louis
22.
go back to reference Daut RL, Cleeland CS, Flanery RC (1983) Development of the Wisconsin brief pain questionnaire to assess pain in cancer and other diseases. Pain 17:197–210PubMedCrossRef Daut RL, Cleeland CS, Flanery RC (1983) Development of the Wisconsin brief pain questionnaire to assess pain in cancer and other diseases. Pain 17:197–210PubMedCrossRef
23.
go back to reference Collins MT, Kushner H, Reynolds JC, Chebli C, Kelly MH, Gupta A, Brillante B, Leet AI, Riminucci M, Robey PG, Bianco P, Wientroub S, Chen CC (2005) An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone. J Bone Miner Res 20:219–226PubMedCrossRef Collins MT, Kushner H, Reynolds JC, Chebli C, Kelly MH, Gupta A, Brillante B, Leet AI, Riminucci M, Robey PG, Bianco P, Wientroub S, Chen CC (2005) An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone. J Bone Miner Res 20:219–226PubMedCrossRef
24.
go back to reference Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS (2004) Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 20:309–318PubMedCrossRef Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS (2004) Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 20:309–318PubMedCrossRef
25.
go back to reference Tan G, Jensen MP, Thornby JI, Shanti BF (2004) Validation of the brief pain inventory for chronic nonmalignant pain. J Pain 5:133–137PubMedCrossRef Tan G, Jensen MP, Thornby JI, Shanti BF (2004) Validation of the brief pain inventory for chronic nonmalignant pain. J Pain 5:133–137PubMedCrossRef
26.
go back to reference Mendoza T, Mayne T, Rublee D, Cleeland C (2005) Reliability and validity of a modified brief pain inventory short form in patients with osteoarthritis. Eur J Pain Mendoza T, Mayne T, Rublee D, Cleeland C (2005) Reliability and validity of a modified brief pain inventory short form in patients with osteoarthritis. Eur J Pain
27.
go back to reference Walco G, Ilowite, NT (1991) Vertical versus horizontal visual analogue scales of pain intensity in children. Journal of Pain Symptom Management 6 Walco G, Ilowite, NT (1991) Vertical versus horizontal visual analogue scales of pain intensity in children. Journal of Pain Symptom Management 6
28.
go back to reference McGrath P (1990) Pain in children. The Guilford Press, New York McGrath P (1990) Pain in children. The Guilford Press, New York
29.
go back to reference Schechter NL (2003) Pain in infants, children and adolescents. Lippincott Williams & Wilkins, Philadelphia Schechter NL (2003) Pain in infants, children and adolescents. Lippincott Williams & Wilkins, Philadelphia
30.
go back to reference Dorfman HD, Czerniak, B (1998) Fibroosseous lesions. In: Dorfman HD, Czerniak B (eds) Bone tumors. Mosby, St. Louis, pp 441–491 Dorfman HD, Czerniak, B (1998) Fibroosseous lesions. In: Dorfman HD, Czerniak B (eds) Bone tumors. Mosby, St. Louis, pp 441–491
31.
go back to reference Brunner HI, Klein-Gitelman MS, Miller MJ, Trombley M, Baldwin N, Kress A, Johnson AL, Barron AC, Griffin TA, Passo MH, Lovell DJ (2004) Health of children with chronic arthritis: relationship of different measures and the quality of parent proxy reporting. Arthritis Rheum 51:763–773PubMedCrossRef Brunner HI, Klein-Gitelman MS, Miller MJ, Trombley M, Baldwin N, Kress A, Johnson AL, Barron AC, Griffin TA, Passo MH, Lovell DJ (2004) Health of children with chronic arthritis: relationship of different measures and the quality of parent proxy reporting. Arthritis Rheum 51:763–773PubMedCrossRef
32.
go back to reference Kim H, Neubert JK, Rowan JS, Brahim JS, Iadarola MJ, Dionne RA (2004) Comparison of experimental and acute clinical pain responses in humans as pain phenotypes. J Pain 5:377–384PubMedCrossRef Kim H, Neubert JK, Rowan JS, Brahim JS, Iadarola MJ, Dionne RA (2004) Comparison of experimental and acute clinical pain responses in humans as pain phenotypes. J Pain 5:377–384PubMedCrossRef
33.
34.
go back to reference Raj PP (2000) Practical management of pain. Mosby, Inc, St Louis Raj PP (2000) Practical management of pain. Mosby, Inc, St Louis
36.
go back to reference Chapurlat R, Delmas PD, Liens D, Meunier PJ (2002) Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 10:1746–1752 Chapurlat R, Delmas PD, Liens D, Meunier PJ (2002) Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 10:1746–1752
37.
go back to reference Parisi MS, Oliveri MB, Gomez Acotto C, Mautalen C (2001) Intravenous pamidronate increases bone mineral density and reduces bone remodeling markers in fibrous dysplasia. Bone 29:300–301CrossRef Parisi MS, Oliveri MB, Gomez Acotto C, Mautalen C (2001) Intravenous pamidronate increases bone mineral density and reduces bone remodeling markers in fibrous dysplasia. Bone 29:300–301CrossRef
38.
go back to reference Zacharin M, O’Sullivan M (2000) Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome. J Pediatr 137:403–409PubMedCrossRef Zacharin M, O’Sullivan M (2000) Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome. J Pediatr 137:403–409PubMedCrossRef
39.
go back to reference Lala R, Matarazzo P, Bertelloni S, Buzi F, Rigon F, de Sanctis C (2000) Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr 89:188–193PubMedCrossRef Lala R, Matarazzo P, Bertelloni S, Buzi F, Rigon F, de Sanctis C (2000) Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr 89:188–193PubMedCrossRef
40.
go back to reference Liens D, Delmas PD, Meunier PJ (1994) Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 343:953–954PubMedCrossRef Liens D, Delmas PD, Meunier PJ (1994) Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 343:953–954PubMedCrossRef
Metadata
Title
Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions
Authors
M. H. Kelly
B. Brillante
M. T. Collins
Publication date
01-01-2008
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 1/2008
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-007-0425-x

Other articles of this Issue 1/2008

Osteoporosis International 1/2008 Go to the issue